Ilenia Calcaterra: RESOLVE Study on Hypertrophic Synovium in Severe Hemophilia A Under Emicizumab
Ilenia Calcaterra, Consultant Physician in Internal Medicine and Assistant Professor at the University of Naples Federico II, shared a post on LinkedIn:
“Honored to have presented our work on hypertrophic synovium in severe haemophilia A during the moderated poster session at the WFH 2026 World Congress in Kuala Lumpur.
It was a real privilege to be among the candidates for the Christine Lee Young Researcher Award for best poster and to share this moment with such talented young researchers from around the world.
Our study, RESOLVE, focused on changes in hypertrophic synovium in adult patients with severe haemophilia A receiving emicizumab prophylaxis.
The data suggest that while emicizumab provides excellent bleed control, meaningful improvement in synovial status can also be observed, reinforcing the importance of joint monitoring and individualized joint health management.
Grateful for this opportunity, for the scientific exchange, and for the chance to contribute to ongoing research in haemophilia care.”
Find more posts featuring Ilenia Calcaterra on Hemostasis Today.
-
May 6, 2026, 02:58Limiaa Babikir: What Is Polyspecific DAT?
-
May 6, 2026, 02:47Karen Rollinson: Grateful to Be Connecting with so Many Families and Advocates at HFA 2026 in New Orleans
-
May 6, 2026, 02:38Moustafa Abdou: Is the Bone Marrow Examination Still the ‘Gold Standard’?
-
May 6, 2026, 02:23Khaled Musallam: When the Worlds of Thalassemia and Hemophilia Converge
-
May 6, 2026, 02:12Caitlin Raymond: How STOP-BABESIOSIS Just Rewrote 40 Years of Practice
-
May 5, 2026, 16:28Nikolay Novitski: A New Era in Cardiovascular Prevention
-
May 5, 2026, 16:23Satyam Arora: Best Abstract Award in Pediatric Apheresis at ASFA 2026 Congress
-
May 5, 2026, 16:17Hannah Omunakwe: Your Sick Child Has a Clot. Did You See That Coming?
-
May 5, 2026, 15:57Venous Thromboembolism Risk in Pregnancy and the Postpartum Period – NBCA